HuagongsheHuagongshe Chemistry Print Report · For research reference only
4-[(2S)Oxiranylmethoxy]-1,3-dihydro-2H-benzimidazol-2-one → 4-(4-(2-[(2S)-2-Hydroxy-3-(2-oxo-2,3-dihydro-1H-benzoimidazol-4-yloxy)-propylamino]-ethoxy}-phenylamino)-piperidine-1-carboxylic acidoctylamide
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 4-[(2S)Oxiranylmethoxy]-1,3-dihydro-2H-benzimidazol-2-one | HCID 10512450 | — |
| Reactant | 4-[4-(2-Aminoethoxy)anilino]-N-octyl-1-piperidinecarboxamide formate | HCID 69987684 | — |
| Solvent | Chloroform methanol | HCID 21584188 | — |
| Product | 4-(4-(2-[(2S)-2-Hydroxy-3-(2-oxo-2,3-dihydro-1H-benzoimidazol-4-yloxy)-propylamino]-ethoxy}-phenylamino)-piperidine-1-carboxylic acidoctylamide | HCID 10145302 | 19.4% |
Reaction Steps
4-[4-(2-Aminoethoxy)anilino]-N-octyl-1-piperidinecarboxamide formate (0.32 g, 0.733 mmol) was reacted with 4-[(2S)oxiranylmethoxy]-1,3-dihydro-2H-benzimidazol-2-one (0.151 g, 0.732 mmol) according to Procedure G (eluant: 20:1 chloroform-methanol) to give the title compound (0.085 g, 0.142 mmol).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US06605618B2 |
| Source dataset | uspto-grants-2003_08 |
| ORD ID | ord-a9379cfb1a1749dea611d3ca35215633 |
| Source note | uspto-grants-2003_08 |